Cargando…
Development and validation of a prognostic nomogram for IgA nephropathy
IgA nephropathy (IgAN) shows strong heterogeneity between individuals. IgAN prognosis is associated with pathological lesions and clinical indicators. However, simple tools for evaluating the clinical prognosis remain inadequate. Our objective was to develop an intuitive estimation tool for predicti...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706880/ https://www.ncbi.nlm.nih.gov/pubmed/29212234 http://dx.doi.org/10.18632/oncotarget.21721 |
_version_ | 1783282306713124864 |
---|---|
author | Liu, Jian Duan, Shuwei Chen, Pu Cai, Guangyan Wang, Yong Tang, Li Liu, Shuwen Zhou, Jianhui Wu, Di Shen, Wanjun Chen, Xiangmei Wu, Jie |
author_facet | Liu, Jian Duan, Shuwei Chen, Pu Cai, Guangyan Wang, Yong Tang, Li Liu, Shuwen Zhou, Jianhui Wu, Di Shen, Wanjun Chen, Xiangmei Wu, Jie |
author_sort | Liu, Jian |
collection | PubMed |
description | IgA nephropathy (IgAN) shows strong heterogeneity between individuals. IgAN prognosis is associated with pathological lesions and clinical indicators. However, simple tools for evaluating the clinical prognosis remain inadequate. Our objective was to develop an intuitive estimation tool for predicting the IgAN prognosis. 349 patients with IgAN at The Chinese People’s Liberation Army General Hospital were retrospectively analyzed from data between 2000 and 2006. A nomogram was developed using COX regression coefficients to predict decline of estimate Glomerular filtration rate (eGFR) ≥ 50% and end-stage renal disease (ESRD). The discriminative ability and predictive accuracy of the nomogram was determined via concordance index (C-index) and calibration curve. The results were verified in an independent validation cohort. In the derivation cohort, the nomogram was developed using mesangial hypercellularity, tubular atrophy/interstitial fibrosis, average proteinuria (A-P), and average mean arterial pressure (A-MAP) during hospitalization. The C-index of the nomogram was 0.88 (95% CI, 0.80 to 0.96). The calibration curve showed good agreement between prediction and actual observation. Furthermore, the nomogram demonstrated good discrimination (C-index = 0.87, 95% CI 0.78 to 0.95) and calibration in the validation cohort. The nomogram could predict the prognosis of IgAN effectively and intuitively. |
format | Online Article Text |
id | pubmed-5706880 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-57068802017-12-05 Development and validation of a prognostic nomogram for IgA nephropathy Liu, Jian Duan, Shuwei Chen, Pu Cai, Guangyan Wang, Yong Tang, Li Liu, Shuwen Zhou, Jianhui Wu, Di Shen, Wanjun Chen, Xiangmei Wu, Jie Oncotarget Research Paper IgA nephropathy (IgAN) shows strong heterogeneity between individuals. IgAN prognosis is associated with pathological lesions and clinical indicators. However, simple tools for evaluating the clinical prognosis remain inadequate. Our objective was to develop an intuitive estimation tool for predicting the IgAN prognosis. 349 patients with IgAN at The Chinese People’s Liberation Army General Hospital were retrospectively analyzed from data between 2000 and 2006. A nomogram was developed using COX regression coefficients to predict decline of estimate Glomerular filtration rate (eGFR) ≥ 50% and end-stage renal disease (ESRD). The discriminative ability and predictive accuracy of the nomogram was determined via concordance index (C-index) and calibration curve. The results were verified in an independent validation cohort. In the derivation cohort, the nomogram was developed using mesangial hypercellularity, tubular atrophy/interstitial fibrosis, average proteinuria (A-P), and average mean arterial pressure (A-MAP) during hospitalization. The C-index of the nomogram was 0.88 (95% CI, 0.80 to 0.96). The calibration curve showed good agreement between prediction and actual observation. Furthermore, the nomogram demonstrated good discrimination (C-index = 0.87, 95% CI 0.78 to 0.95) and calibration in the validation cohort. The nomogram could predict the prognosis of IgAN effectively and intuitively. Impact Journals LLC 2017-10-10 /pmc/articles/PMC5706880/ /pubmed/29212234 http://dx.doi.org/10.18632/oncotarget.21721 Text en Copyright: © 2017 Liu et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Liu, Jian Duan, Shuwei Chen, Pu Cai, Guangyan Wang, Yong Tang, Li Liu, Shuwen Zhou, Jianhui Wu, Di Shen, Wanjun Chen, Xiangmei Wu, Jie Development and validation of a prognostic nomogram for IgA nephropathy |
title | Development and validation of a prognostic nomogram for IgA nephropathy |
title_full | Development and validation of a prognostic nomogram for IgA nephropathy |
title_fullStr | Development and validation of a prognostic nomogram for IgA nephropathy |
title_full_unstemmed | Development and validation of a prognostic nomogram for IgA nephropathy |
title_short | Development and validation of a prognostic nomogram for IgA nephropathy |
title_sort | development and validation of a prognostic nomogram for iga nephropathy |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706880/ https://www.ncbi.nlm.nih.gov/pubmed/29212234 http://dx.doi.org/10.18632/oncotarget.21721 |
work_keys_str_mv | AT liujian developmentandvalidationofaprognosticnomogramforiganephropathy AT duanshuwei developmentandvalidationofaprognosticnomogramforiganephropathy AT chenpu developmentandvalidationofaprognosticnomogramforiganephropathy AT caiguangyan developmentandvalidationofaprognosticnomogramforiganephropathy AT wangyong developmentandvalidationofaprognosticnomogramforiganephropathy AT tangli developmentandvalidationofaprognosticnomogramforiganephropathy AT liushuwen developmentandvalidationofaprognosticnomogramforiganephropathy AT zhoujianhui developmentandvalidationofaprognosticnomogramforiganephropathy AT wudi developmentandvalidationofaprognosticnomogramforiganephropathy AT shenwanjun developmentandvalidationofaprognosticnomogramforiganephropathy AT chenxiangmei developmentandvalidationofaprognosticnomogramforiganephropathy AT wujie developmentandvalidationofaprognosticnomogramforiganephropathy |